Product Information
RASAGILINE MESYLATE 1 MG TAB is a generic product labeled by Avet Pharmaceuticals Inc., priced at $0.9255 per EA under NDC 23155074703. Its NADAC has been published 316 times since Sep 16, 2020.
FDA first approved this application on Oct 4, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/1
Manufacturer
Avet Pharmaceuticals Inc.NDC
23155074703
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
RASAGILINE MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA206153FDA Approved
10/4/2019
TE Code
AB
On Market Since
5/31/2023
Pharmacological Classes
Price Statistics
The NADAC for RASAGILINE MESYLATE 1 MG TAB has been published 316 times since Sep 16, 2020, and over the history we have for it it has declined 78.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9255 per EA |
|---|---|
| All-time high | $4.4835 (Nov 11, 2020) |
| All-time low | $0.8798 (Oct 18, 2023) |
| 52-week high | $1.1267 |
| 52-week low | $0.9255 |
| Median price | $1.3064 |
| Average price | $1.6476 |
| Largest weekly change | +60.0% (Jul 21, 2021) |
| Weeks tracked | 316 |
| Tracking since | Sep 16, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Avet Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Rasagiline mesylate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Monoamine Oxidase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RASAGILINE MESYLATE 1 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for RASAGILINE MESYLATE 1 MG TAB, manufactured by Avet Pharmaceuticals Inc., is $0.9255 per EA (NDC 23155074703), effective Sep 30, 2026.
How has the price of RASAGILINE MESYLATE 1 MG TAB changed over time?
Over the history we have for it, the NADAC for RASAGILINE MESYLATE 1 MG TAB has declined 78.0%. It has been tracked across 316 weekly CMS publications since Sep 16, 2020.
What are the highest and lowest recorded NADAC prices for RASAGILINE MESYLATE 1 MG TAB?
Since Sep 16, 2020, the NADAC for RASAGILINE MESYLATE 1 MG TAB has ranged from a low of $0.8798 (Oct 18, 2023) to a high of $4.4835 (Nov 11, 2020), with a median of $1.3064 per EA.
Are there cheaper alternatives to RASAGILINE MESYLATE 1 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as RASAGILINE MESYLATE 1 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures RASAGILINE MESYLATE 1 MG TAB?
RASAGILINE MESYLATE 1 MG TAB (NDC 23155074703) is labeled by Avet Pharmaceuticals Inc., and CMS classifies it as a generic product.